Lima, W. G. d., Candido, P. d. A., Sabino, A. d. P., Cardoso, V. N., & Fernandes, S. O. A. (2022). Serum adipokines as biomarkers for the therapeutic monitoring of patients with inflammatory bowel diseases (IBDs) treated with infliximab: A systematic review and meta-analysis.
Citación estilo ChicagoLima, William Gustavo de, Patrícia de Alcantara Candido, Adriano de Paula Sabino, Valbert Nascimento Cardoso, y Simone Odília Antunes Fernandes. Serum Adipokines As Biomarkers for the Therapeutic Monitoring of Patients With Inflammatory Bowel Diseases (IBDs) Treated With Infliximab: A Systematic Review and Meta-analysis. 2022.
Cita MLALima, William Gustavo de, et al. Serum Adipokines As Biomarkers for the Therapeutic Monitoring of Patients With Inflammatory Bowel Diseases (IBDs) Treated With Infliximab: A Systematic Review and Meta-analysis. 2022.